
Global Actinic Keratosis Treatment Industry Growth and Trends Forecast to 2031
Description
Summary
Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.
According to APO Research, The global Actinic Keratosis Treatment market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Actinic Keratosis Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Actinic Keratosis Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Actinic Keratosis Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Actinic Keratosis Treatment include DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical, Galderma (Nestle), Biofrontera and Almirall, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Actinic Keratosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Actinic Keratosis Treatment.
The Actinic Keratosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Actinic Keratosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Actinic Keratosis Treatment Segment by Company
DUSA Pharmaceuticals
Novartis
Perrigo
LEO Pharma
Bausch Health
Taro Pharmaceutical
Galderma (Nestle)
Biofrontera
Almirall
Tolmar Pharmaceutical
Actinic Keratosis Treatment Segment by Type
Destructive Treatment
Photodynamic Therapy
Topical Medications
Others
Actinic Keratosis Treatment Segment by Application
Hospital
Clinic
Others
Actinic Keratosis Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Actinic Keratosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Actinic Keratosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Actinic Keratosis Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Actinic Keratosis Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.
According to APO Research, The global Actinic Keratosis Treatment market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Actinic Keratosis Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Actinic Keratosis Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Actinic Keratosis Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Actinic Keratosis Treatment include DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical, Galderma (Nestle), Biofrontera and Almirall, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Actinic Keratosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Actinic Keratosis Treatment.
The Actinic Keratosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Actinic Keratosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Actinic Keratosis Treatment Segment by Company
DUSA Pharmaceuticals
Novartis
Perrigo
LEO Pharma
Bausch Health
Taro Pharmaceutical
Galderma (Nestle)
Biofrontera
Almirall
Tolmar Pharmaceutical
Actinic Keratosis Treatment Segment by Type
Destructive Treatment
Photodynamic Therapy
Topical Medications
Others
Actinic Keratosis Treatment Segment by Application
Hospital
Clinic
Others
Actinic Keratosis Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Actinic Keratosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Actinic Keratosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Actinic Keratosis Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Actinic Keratosis Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
102 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Actinic Keratosis Treatment Market Size Overview by Region 2020 VS 2024 VS 2031
- 1.4 Global Actinic Keratosis Treatment Market Size by Region (2020-2031)
- 1.4.1 Global Actinic Keratosis Treatment Market Size by Region (2020-2025)
- 1.4.2 Global Actinic Keratosis Treatment Market Size by Region (2026-2031)
- 1.5 Key Regions Actinic Keratosis Treatment Market Size (2020-2031)
- 1.5.1 North America Actinic Keratosis Treatment Market Size Growth Rate (2020-2031)
- 1.5.2 Europe Actinic Keratosis Treatment Market Size Growth Rate (2020-2031)
- 1.5.3 Asia-Pacific Actinic Keratosis Treatment Market Size Growth Rate (2020-2031)
- 1.5.4 South America Actinic Keratosis Treatment Market Size Growth Rate (2020-2031)
- 1.5.5 Middle East & Africa Actinic Keratosis Treatment Market Size Growth Rate (2020-2031)
- 2 Actinic Keratosis Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Destructive Treatment
- 2.1.2 Photodynamic Therapy
- 2.1.3 Topical Medications
- 2.1.4 Others
- 2.2 Global Actinic Keratosis Treatment Market Size by Type
- 2.2.1 Global Actinic Keratosis Treatment Market Size Overview by Type (2020-2031)
- 2.2.2 Global Actinic Keratosis Treatment Historic Market Size Review by Type (2020-2025)
- 2.2.3 Global Actinic Keratosis Treatment Market Size Forecasted by Type (2026-2031)
- 2.3 Global Actinic Keratosis Treatment Market Size by Regions
- 2.3.1 North America Actinic Keratosis Treatment Market Size Breakdown by Type (2020-2025)
- 2.3.2 Europe Actinic Keratosis Treatment Market Size Breakdown by Type (2020-2025)
- 2.3.3 Asia-Pacific Actinic Keratosis Treatment Market Size Breakdown by Type (2020-2025)
- 2.3.4 South America Actinic Keratosis Treatment Market Size Breakdown by Type (2020-2025)
- 2.3.5 Middle East and Africa Actinic Keratosis Treatment Market Size Breakdown by Type (2020-2025)
- 3 Actinic Keratosis Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Others
- 3.2 Global Actinic Keratosis Treatment Market Size by Application
- 3.2.1 Global Actinic Keratosis Treatment Market Size Overview by Application (2020-2031)
- 3.2.2 Global Actinic Keratosis Treatment Historic Market Size Review by Application (2020-2025)
- 3.2.3 Global Actinic Keratosis Treatment Market Size Forecasted by Application (2026-2031)
- 3.3 Global Actinic Keratosis Treatment Market Size by Regions
- 3.3.1 North America Actinic Keratosis Treatment Market Size Breakdown by Application (2020-2025)
- 3.3.2 Europe Actinic Keratosis Treatment Market Size Breakdown by Application (2020-2025)
- 3.3.3 Asia-Pacific Actinic Keratosis Treatment Market Size Breakdown by Application (2020-2025)
- 3.3.4 South America Actinic Keratosis Treatment Market Size Breakdown by Application (2020-2025)
- 3.3.5 Middle East and Africa Actinic Keratosis Treatment Market Size Breakdown by Application (2020-2025)
- 4 Global Market Dynamics
- 4.1 Actinic Keratosis Treatment Industry Trends
- 4.2 Actinic Keratosis Treatment Industry Drivers
- 4.3 Actinic Keratosis Treatment Industry Opportunities and Challenges
- 4.4 Actinic Keratosis Treatment Industry Restraints
- 5 Competitive Insights by Company
- 5.1 Global Top Players by Actinic Keratosis Treatment Revenue (2020-2025)
- 5.2 Global Actinic Keratosis Treatment Industry Company Ranking, 2023 VS 2024 VS 2025
- 5.3 Global Actinic Keratosis Treatment Key Company Headquarters & Area Served
- 5.4 Global Actinic Keratosis Treatment Company, Product Type & Application
- 5.5 Global Actinic Keratosis Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Actinic Keratosis Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Actinic Keratosis Treatment Players Market Share by Revenue in 2024
- 5.6.3 2024 Actinic Keratosis Treatment Tier 1, Tier 2, and Tier 3
- 6 Company Profiles
- 6.1 DUSA Pharmaceuticals
- 6.1.1 DUSA Pharmaceuticals Comapny Information
- 6.1.2 DUSA Pharmaceuticals Business Overview
- 6.1.3 DUSA Pharmaceuticals Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.1.4 DUSA Pharmaceuticals Actinic Keratosis Treatment Product Portfolio
- 6.1.5 DUSA Pharmaceuticals Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Comapny Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.2.4 Novartis Actinic Keratosis Treatment Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Perrigo
- 6.3.1 Perrigo Comapny Information
- 6.3.2 Perrigo Business Overview
- 6.3.3 Perrigo Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.3.4 Perrigo Actinic Keratosis Treatment Product Portfolio
- 6.3.5 Perrigo Recent Developments
- 6.4 LEO Pharma
- 6.4.1 LEO Pharma Comapny Information
- 6.4.2 LEO Pharma Business Overview
- 6.4.3 LEO Pharma Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.4.4 LEO Pharma Actinic Keratosis Treatment Product Portfolio
- 6.4.5 LEO Pharma Recent Developments
- 6.5 Bausch Health
- 6.5.1 Bausch Health Comapny Information
- 6.5.2 Bausch Health Business Overview
- 6.5.3 Bausch Health Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.5.4 Bausch Health Actinic Keratosis Treatment Product Portfolio
- 6.5.5 Bausch Health Recent Developments
- 6.6 Taro Pharmaceutical
- 6.6.1 Taro Pharmaceutical Comapny Information
- 6.6.2 Taro Pharmaceutical Business Overview
- 6.6.3 Taro Pharmaceutical Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.6.4 Taro Pharmaceutical Actinic Keratosis Treatment Product Portfolio
- 6.6.5 Taro Pharmaceutical Recent Developments
- 6.7 Galderma (Nestle)
- 6.7.1 Galderma (Nestle) Comapny Information
- 6.7.2 Galderma (Nestle) Business Overview
- 6.7.3 Galderma (Nestle) Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.7.4 Galderma (Nestle) Actinic Keratosis Treatment Product Portfolio
- 6.7.5 Galderma (Nestle) Recent Developments
- 6.8 Biofrontera
- 6.8.1 Biofrontera Comapny Information
- 6.8.2 Biofrontera Business Overview
- 6.8.3 Biofrontera Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.8.4 Biofrontera Actinic Keratosis Treatment Product Portfolio
- 6.8.5 Biofrontera Recent Developments
- 6.9 Almirall
- 6.9.1 Almirall Comapny Information
- 6.9.2 Almirall Business Overview
- 6.9.3 Almirall Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.9.4 Almirall Actinic Keratosis Treatment Product Portfolio
- 6.9.5 Almirall Recent Developments
- 6.10 Tolmar Pharmaceutical
- 6.10.1 Tolmar Pharmaceutical Comapny Information
- 6.10.2 Tolmar Pharmaceutical Business Overview
- 6.10.3 Tolmar Pharmaceutical Actinic Keratosis Treatment Revenue, Global Share and Gross Margin (2020-2025)
- 6.10.4 Tolmar Pharmaceutical Actinic Keratosis Treatment Product Portfolio
- 6.10.5 Tolmar Pharmaceutical Recent Developments
- 7 North America
- 7.1 North America Actinic Keratosis Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2 North America Actinic Keratosis Treatment Market Size by Country (2020-2025)
- 7.3 North America Actinic Keratosis Treatment Market Size Forecast by Country (2026-2031)
- 8 Europe
- 8.1 Europe Actinic Keratosis Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2 Europe Actinic Keratosis Treatment Market Size by Country (2020-2025)
- 8.3 Europe Actinic Keratosis Treatment Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Actinic Keratosis Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Country (2020-2025)
- 9.3 Asia-Pacific Actinic Keratosis Treatment Market Size Forecast by Country (2026-2031)
- 10 South America
- 10.1 South America Actinic Keratosis Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2 South America Actinic Keratosis Treatment Market Size by Country (2020-2025)
- 10.3 South America Actinic Keratosis Treatment Market Size Forecast by Country (2026-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Actinic Keratosis Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Country (2020-2025)
- 11.3 Middle East & Africa Actinic Keratosis Treatment Market Size Forecast by Country (2026-2031)
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.